2010
DOI: 10.4161/gmic.1.3.12485
|View full text |Cite
|
Sign up to set email alerts
|

Probiotics and Iletis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 52 publications
0
7
0
Order By: Relevance
“…Current medical treatments for IBD generally include 5-aminosalicylates or sulfasalazine, antibiotics, corticosteroids, immunomodulators and biological therapies (e.g., monoclonal antibodies). However, despite their efficacy, some patients are unresponsive to these therapies and often suffer from numerous side effects [40-42]. Thus, it is still necessary to develop new and specific therapies for IBD.…”
Section: Discussionmentioning
confidence: 99%
“…Current medical treatments for IBD generally include 5-aminosalicylates or sulfasalazine, antibiotics, corticosteroids, immunomodulators and biological therapies (e.g., monoclonal antibodies). However, despite their efficacy, some patients are unresponsive to these therapies and often suffer from numerous side effects [40-42]. Thus, it is still necessary to develop new and specific therapies for IBD.…”
Section: Discussionmentioning
confidence: 99%
“…Many probiotic effects are mediated through immune regulation, particularly through balance control of proinflammatory and anti-inflammatory cytokines (Di Giacinto, Marinaro, Sanchez, Strober, & Boirivant, 1950;Foligne et al, 2010;Hacini-Rachinel et al, 1950;Jobin, 2010;Li, Xia, & Li, 2009). However, several animal and human studies have provided unequivocal evidence that specific strains of probiotics are able to stimulate several aspects of innate immunity (Amit-Romach et al, 2010;Boirivant et al, 2008;Boirivant & Strober, 2007;Farnell et al, 2006;Romanin et al, 2010;Weiss et al, 2010) as well as to increase humoral immunity (Fang, Elina, Heikki, & Seppo, 2000;Galdeano, de Leblanc Ade, Carmuega, Weill, & Perdigon, 2009;Leblanc, Fliss, & Matar, 2004;Nermes, Kantele, Atosuo, Salminen, & Isolauri, 2011).…”
Section: A Lactic Acid Bacteria-based Probiotic For Salmonella Contromentioning
confidence: 99%
“…Unfortunately, therapeutic options currently available for the treatment of IBD are largely limited to symptoms of the disease, with some exceptions to the molecular pathways associated with intestinal inflammation ( Jobin, 2010 ; Okafor et al, 2013 ). Despite advances in therapeutics, some patients didn’t respond to treatment or suffered from side effects or complications ( Dou et al, 2014 ).…”
Section: Introductionmentioning
confidence: 99%